Status:
COMPLETED
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Suicide
Psychosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study...
Eligibility Criteria
Inclusion
- Schizophrenia Spectrum Disorder
- Suicide ideation and/or attempt within 3 months of screening
- Ability to speak and read in English
- 18 to 65 years of age
Exclusion
- Requiring emergency care (e.g. imminent plan to harm self) as determined by trained research staff administering the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Inappropriate for behavioral treatment according to own judgment in consultation with a treating clinician CMH
- Impaired capacity (cognitive capacity)
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04689867
Start Date
September 1 2021
End Date
April 11 2022
Last Update
April 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109